One step further towards an HIV vaccine: and this one performed as expected
Generic antiretrovirals could save NHS £1.25 billion over 5 years, study finds
Longer time to virological failure and less drug resistance seen in people taking Atripla than in people taking separate drugs
Gilead two-drug hep C combination cures 94% of genotype 1 patients in eight weeks
Dolutegravir matches or surpasses other regimens for first-line HIV treatment
US PrEP prescriptions more likely to go to Southern women
Non-African middle-income countries pay four times more for ARVs than African middle-income countries
